Functional Network Analysis Reveals the Relevance of SKIIP in the Regulation of Alternative Splicing by p38 SAPK.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
16 04 2019
Historique:
received: 03 09 2018
revised: 21 02 2019
accepted: 15 03 2019
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 17 6 2020
Statut: ppublish

Résumé

Alternative splicing is a prevalent mechanism of gene regulation that is modulated in response to a wide range of extracellular stimuli. Stress-activated protein kinases (SAPKs) play a key role in controlling several steps of mRNA biogenesis. Here, we show that osmostress has an impact on the regulation of alternative splicing (AS), which is partly mediated through the action of p38 SAPK. Splicing network analysis revealed a functional connection between p38 and the spliceosome component SKIIP, whose depletion abolished a significant fraction of p38-mediated AS changes. Importantly, p38 interacted with and directly phosphorylated SKIIP, thereby altering its activity. SKIIP phosphorylation regulated AS of GADD45α, the upstream activator of the p38 pathway, uncovering a negative feedback loop involving AS regulation. Our data reveal mechanisms and targets of SAPK function in stress adaptation through the regulation of AS.

Identifiants

pubmed: 30995481
pii: S2211-1247(19)30390-0
doi: 10.1016/j.celrep.2019.03.060
pmc: PMC6484779
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
GADD45A protein, human 0
Imidazoles 0
Nuclear Receptor Coactivators 0
Protein Isoforms 0
Pyridines 0
RNA, Small Interfering 0
SNW1 protein, human 0
Sodium Chloride 451W47IQ8X
Protein-Tyrosine Kinases EC 2.7.10.1
Protein Serine-Threonine Kinases EC 2.7.11.1
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24
MAP Kinase Kinase 6 EC 2.7.12.2
MAP2K6 protein, human EC 2.7.12.2
SB 203580 OU13V1EYWQ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

847-859.e6

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Mol Cell Biol. 2007 Apr;27(7):2765-76
pubmed: 17242196
Cell Rep. 2014 Jun 12;7(5):1362-1370
pubmed: 24857664
EMBO J. 1998 Aug 17;17(16):4744-52
pubmed: 9707433
Oncol Rep. 2015 Mar;33(3):1115-22
pubmed: 25607636
Nucleic Acids Res. 2011 Mar;39(5):1868-79
pubmed: 21062807
Cell. 2014 Dec 18;159(7):1511-23
pubmed: 25525873
Cancer Med. 2015 Feb;4(2):268-77
pubmed: 25450007
Mol Cell. 2015 Jan 8;57(1):7-22
pubmed: 25482510
J Biol Chem. 2010 Oct 8;285(41):31819-28
pubmed: 20682780
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14440-5
pubmed: 11717410
Trends Biochem Sci. 2009 Mar;34(3):146-53
pubmed: 19208481
Genes Dev. 2011 Apr 1;25(7):701-16
pubmed: 21460037
Mol Cell. 2015 Jan 8;57(1):23-38
pubmed: 25482508
Biochem Biophys Res Commun. 1988 Apr 29;152(2):717-23
pubmed: 3365249
J Cell Biol. 2000 Apr 17;149(2):307-16
pubmed: 10769024
Oncotarget. 2017 May 29;8(33):55684-55714
pubmed: 28903453
Curr Mol Med. 2012 Jun;12(5):634-51
pubmed: 22515981
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
EMBO J. 2012 Jan 18;31(2):301-16
pubmed: 22068056
Cell Mol Life Sci. 2004 Mar;61(6):629-40
pubmed: 15052407
Cell. 1998 Nov 13;95(4):521-30
pubmed: 9827804
Int J Mol Sci. 2017 Feb 20;18(2):
pubmed: 28230724
BMC Genomics. 2010 Mar 01;11:144
pubmed: 20187982
Genome Biol. 2009;10(1):R11
pubmed: 19178699
Mol Cell. 2009 Oct 9;36(1):75-87
pubmed: 19818711
Nature. 2008 Apr 17;452(7189):846-50
pubmed: 18322460
Mol Plant. 2015 Jul;8(7):1038-52
pubmed: 25617718
Mol Cell Biol. 2014 Aug;34(15):2857-73
pubmed: 24865968
PLoS Comput Biol. 2010 Nov 24;6(11):e1001016
pubmed: 21124863
Nat Struct Mol Biol. 2007 Dec;14(12):1150-6
pubmed: 18026121
Mol Cell Biol. 2006 Aug;26(15):5744-58
pubmed: 16847328
Bioinformatics. 2019 Jan 1;35(1):130-132
pubmed: 30010778
Nat Commun. 2018 Mar 9;9(1):1017
pubmed: 29523821
FEBS J. 2015 Sep;282(17):3275-85
pubmed: 25996081
Cancer Res. 2016 Dec 15;76(24):7277-7289
pubmed: 27864346
BMC Biochem. 2013 Apr 08;14:10
pubmed: 23566155
Curr Opin Cell Biol. 2013 Apr;25(2):272-7
pubmed: 23434067
Genes Dev. 2015 Oct 1;29(19):2054-66
pubmed: 26443849
Biomolecules. 2015 Oct 29;5(4):2935-77
pubmed: 26529031
Mol Cell. 2016 Oct 6;64(1):25-36
pubmed: 27642049
EMBO J. 2004 Jun 16;23(12):2381-91
pubmed: 15175653
Cell. 2006 Dec 1;127(5):887-90
pubmed: 17129776
Gene. 2013 Jan 15;513(1):1-13
pubmed: 23123731
Cell Rep. 2014 Apr 24;7(2):501-513
pubmed: 24726367
Gene. 2018 Jan 10;639:111-116
pubmed: 29020616
BMC Cancer. 2008 Sep 15;8:260
pubmed: 18793421
J Biol Chem. 2000 Dec 22;275(51):40641-8
pubmed: 11010976
FEBS J. 2015 May;282(10):1841-57
pubmed: 25728574
Cell Rep. 2012 May 31;1(5):543-56
pubmed: 22832277
Genome Res. 2017 Oct;27(10):1759-1768
pubmed: 28855263
Biochem J. 2010 Aug 1;429(3):403-17
pubmed: 20626350
EMBO J. 2014 Nov 18;33(22):2643-58
pubmed: 25257309
Cell Stem Cell. 2011 Sep 2;9(3):233-46
pubmed: 21885019
Mol Carcinog. 2009 May;48(5):454-64
pubmed: 18942077
Cell Death Differ. 2017 Sep;24(9):1488-1501
pubmed: 28644436
Genome Res. 2019 Jan;29(1):18-28
pubmed: 30523037
Mol Cell Biol. 2002 Jul;22(13):4544-55
pubmed: 12052864
J Biol Chem. 2003 Sep 12;278(37):35325-36
pubmed: 12840015
PLoS One. 2017 Apr 26;12(4):e0176382
pubmed: 28445500
EMBO J. 2012 Jun 29;31(13):2952-64
pubmed: 22569127
Cell. 2014 Jun 19;157(7):1724-34
pubmed: 24949979
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
Gene. 2016 Jan 10;575(2 Pt 2):369-376
pubmed: 26390817
Mol Cell Biol. 2012 Jul;32(14):2880-93
pubmed: 22615491
Cell. 2009 May 15;137(4):708-20
pubmed: 19450518
RNA Biol. 2011 Sep-Oct;8(5):740-7
pubmed: 21712650
J Cell Sci. 2004 Aug 1;117(Pt 17):3715-23
pubmed: 15286173
Int J Cell Biol. 2013;2013:151839
pubmed: 24069033
Physiol Rev. 2012 Apr;92(2):689-737
pubmed: 22535895
Genome Biol. 2012 Nov 18;13(11):R106
pubmed: 23158682
J Biol Chem. 1998 Jan 16;273(3):1741-8
pubmed: 9430721
Oncotarget. 2016 Apr 19;7(16):21939-51
pubmed: 26959880
Nat Genet. 2004 Jul;36(7):738-43
pubmed: 15208625
Biochem J. 2015 Apr 1;467(1):77-90
pubmed: 25588078

Auteurs

Caterina Carbonell (C)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.

Arnau Ulsamer (A)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.

Claudia Vivori (C)

Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain.

Panagiotis Papasaikas (P)

Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain.

René Böttcher (R)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac, 10, 08028 Barcelona, Spain.

Manel Joaquin (M)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac, 10, 08028 Barcelona, Spain.

Belén Miñana (B)

Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain.

Juan Ramón Tejedor (JR)

Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain.

Eulàlia de Nadal (E)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac, 10, 08028 Barcelona, Spain. Electronic address: eulalia.nadal@irbbarcelona.org.

Juan Valcárcel (J)

Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluis Companys 23, 08010 Barcelona, Spain. Electronic address: juan.valcarcel@crg.eu.

Francesc Posas (F)

Cell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac, 10, 08028 Barcelona, Spain. Electronic address: francesc.posas@irbbarcelona.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH